Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-07-31): -151064.00%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
-71280.19%
NET PROFIT MARGIN AVG 3Y
-25791.25%
NET PROFIT MARGIN AVG 5Y
-26443.94%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$8.11M
Net Profit Margin
N/A
TTM Avg
-71280.19%
3Y Avg
-25791.25%
5Y Avg
-26443.94%
Market Cap
$8.12M
Net Profit Margin
0.00%
TTM Avg
-431.21%
3Y Avg
-828.00%
5Y Avg
-552.00%
Market Cap
$7.95M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.25M
Net Profit Margin
-1100.30%
TTM Avg
-235.88%
3Y Avg
-120.03%
5Y Avg
-120.03%
Market Cap
$8.48M
Net Profit Margin
-66.29%
TTM Avg
-59.63%
3Y Avg
-44.17%
5Y Avg
-31.01%
Market Cap
$7.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.33M
Net Profit Margin
-1977.59%
TTM Avg
-1280.67%
3Y Avg
-1780.71%
5Y Avg
-1415.68%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $8.11M | N/A | -71280.19% | -25791.25% | -26443.94% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.12M | 0.00% | -431.21% | -828.00% | -552.00% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.25M | -1100.30% | -235.88% | -120.03% | -120.03% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.48M | -66.29% | -59.63% | -44.17% | -31.01% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Longeveron Inc. (LGVN)vs › | $7.33M | -1977.59% | -1280.67% | -1780.71% | -1415.68% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -0.61% | -82.77% | -131.16% | -372.00% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | -151064.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | -97179.37% |
| 2025-07-31 | -108157.58% |
| 2025-04-30 | -48145.49% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | -11182.39% |
| 2023-10-31 | -44830.21% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | -68826.41% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | -49165.72% |
| 2022-04-30 | -49485.06% |
| 2022-01-31 | -45200.84% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | -6705.65% |
| 2021-04-30 | -5696.14% |
